What is the concern about Singulair (montelukast)?
Singulair is a major drug in asthma treatment – it is important to review recent developments and put these findings in perspective of overall asthma care for individual patients.
Singulair (montelukast)
Singulair (manufactured and marketed by Merck and Co.) is a drug of the so-called anti-leukotriene class that is used for control of symptoms of asthma and allergic rhinitis (hay fever). It was initially approved by the U.S. Food and Drug...
Did you see the reports last week that Singulair was going to be investigated by the Food and Drug Administration for reports of a "casual... Read more »
The FDA has announced it is investigating a possible association between the use of Singulair and behavior/mood changes, suicidality... Read more »
In March 2008, in a pre-emptive move, Merck announced that its allergy/asthma drug, Singulair, might cause some people to act on suicidal... Read more »
My e-mail is buzzing. "Have you seen the news about Singulair? Are you worried?" The short answer is, "No, I'm not concerned at all." ... Read more »
Children who take Singulair (montelukast) do not experience adverse effects on growth when compared to children treated with inhaled corticosteroids... Read more »
Researchers from the American Lung Association (ALA) say they've found no link between the asthma drug Singulair and an increased risk of suicide and... Read more »
A study at the University of Chicago has found "no significant difference" between the over-the-counter drug Sudafed 24 Hour (pseudoephedrine... Read more »
The asthma med Singulair may help speed up recovery of the common cold. In a new study, patients who took Singulair experienced a 50-percent... Read more »
A new study suggests that children treated with Singulair missed fewer school days than those who took a placebo. Researchers say the kids who took... Read more »